|
Match
|
Document |
Document Title |
|
|
8440702 |
1,3-oxazolidin -2-one derivatives useful as CETP inhibitors
Compounds having the structure of Formula I, including pharmaceutically acceptable salts of the compounds, are CETP inhibitors, and are useful for raising HDL-cholesterol, reducing LDL-cholesterol,...
|
|
|
8440700 |
Substituted aryloxazoles and their use
The present application relates to novel substituted aryloxazole derivatives, to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and to their use for...
|
|
|
8440701 |
Trisubstituted 1,2,4 triazoles
The present invention relates to substituted 1-(alkyl)-3-aniline-5-aryl triazole derivatives and analogues or pharmaceutically acceptable salts thereof, processes for preparing them, pharmaceutical...
|
|
|
8435999 |
Compositions and methods for controlling nematodes
Compositions and processes for controlling nematodes are described herein, e.g., nematodes that infest plants or animals. The compounds include oxazoles, oxadiazoles and thiadiazoles.
|
|
|
8431606 |
Medicament for treating schizophrenia comprising cilostazol
The invention relates to a medicament for preventing and/or treating schizophrenia which comprises as an active ingredient cilostazol or a pharmaceutically acceptable salt thereof.
|
|
|
8420676 |
Oxazolidinone derivatives
The present invention relates to novel derivatives of oxazolidinone, a method thereof and pharmaceutical compositions comprising the derivatives for use in an antibiotic. The oxazolidinone...
|
|
|
8415359 |
Phenylpyrrole derivative
The present invention relates to a compound or a pharmacologically acceptable salt thereof having superior glucokinase activating activity, and is a compound represented by general formula (I), or...
|
|
|
8410145 |
Insecticidal compounds
A compound of formula (I): wherein A1, A2, A3, A4, G1, R1, R2, R3 and R4 are as defined in claim 1; or a salt or N-oxide thereof. Furthermore, the present invention relates to processes and...
|
|
|
8404676 |
Oxadiazole diaryl compounds
The invention relates to compounds of formula (I): wherein R1, R2, Ra, Rb, Rc and W, have the meanings given in claim 16. The compounds are useful e.g. in the treatment of autoimmune disorders,...
|
|
|
8404722 |
Oxazole compounds compositions and methods of use
The present invention relates generally to compounds represented in Formula (I), pharmaceutical compositions comprising them and methods of treating of diseases or disorders such as cancer.
|
|
|
8404726 |
Activating agent for peroxisome proliferator activated receptor δ
A compound represented by the following general formula (II) or a salt thereof is used as an activator of PPARδ. wherein Ga is O, CH2 or the like;Aa is thiazole, oxazole, or thiophene, which can ...
|
|
|
8399493 |
Pyridinone derivatives and their use as positive allosteric modulators of mGluR2-receptors
The present invention relates to methods for treating or controlling schizophrenia in a mammal using compounds having the Formula (I), wherein M1 and M2 are defined in the application.
|
|
|
8399494 |
2,5-disubstituted phenyl carboxamide orexin receptor antagonists
The present invention is directed to 2,5-disubstituted phenyl carboxamide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological...
|
|
|
8399492 |
Pyridine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
The present invention relates to novel pyridine derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of...
|
|
|
8394837 |
2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease
The present invention is directed to 2,3,4,6-substituted pyridyl derivative compounds which are inhibitors of the beta-secretase enzyme and that are useful in the treatment of diseases in which the...
|
|
|
8389549 |
Substituted pyridines useful for treating pain
A compound of Formula: (I) or a pharmaceutically acceptable derivative thereof, where Ar1, Ar2, X, R3, and m are as disclosed herein. Compounds of Formulae (I)-(V) and pharmaceutically acceptable...
|
|
|
8389546 |
Compounds for modulating TRPV3 function
The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.
|
|
|
8389550 |
Isoxazoles / O-pyridines with ethyl and ethenyl linker
The present invention is concerned with novel isoxazole-pyridines of formula I wherein R1, R2, R3 and L are as described herein, as well as pharmaceutically acceptable salts and esters thereof. The...
|
|
|
8383660 |
Dibenzyl amine compounds and derivatives
Dibenzyl amine compounds and derivatives of Formula I, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high...
|
|
|
8377942 |
Isoxazolines derivatives and their use as pesticide
Novel isoxazoline compounds, compositions containing the compounds and methods for making the compounds are disclosed. The compounds and compositions have pesticidal properties and are suitable for...
|
|
|
8377971 |
Non-flushing niacin analogues, and methods of use thereof
One aspect of the present invention relates to substituted pyridines and pharmaceutically acceptable salts thereof that are active against a range of mammalian maladies. Another aspect of the...
|
|
|
8377938 |
Phenoxypyridine derivative salts and crystals thereof, and process for preparing the same
The invention provides acid addition salts of the compounds represented by formula (1) or (2), or crystals thereof, and processes for preparing the same. The salts or crystals have HGFR inhibitory...
|
|
|
8372807 |
Methods of modulating uric acid levels
Described herein are compounds useful in the reduction of blood uric acid levels, formulations containing them and methods of making and using them. In some embodiments, a compound disclosed herein...
|
|
|
8372867 |
Insecticidal aryl isoxazoline derivatives
The present invention relates to novel aryl isoxazoline derivatives having excellent insecticidal activity as insecticides and represented by the formula: and their use as insecticides and acarizides.
|
|
|
8357703 |
Pyridines
The present invention is concerned with novel isoxazoles of formula I wherein X, R1, R2, R3 and R4 are as described herein, as well as pharmaceutically acceptable salts and esters thereof. The...
|
|
|
8343952 |
Prolyl hydroxylase inhibitors and methods of use
The present disclosure relates to HIF-1α prolyl hydroxylase inhibitors, compositions which comprise the HIF-1α prolyl hydroxylase inhibitors described herein and to methods for controlling, inter a...
|
|
|
8344002 |
Compound having β-secretase inhibitory activity
A novel compound represented by the formula (1) below which has β-secretase inhibitory activity, its pharmaceutically acceptable salt or a prodrug thereof. wherein Ar is a substituted or ...
|
|
|
8329706 |
Oxazolidinone derivatives
The present invention relates to oxazolidinone derivatives of formula (I) wherein Y, R3 and R4 are as described in the description, to their preparation, to pharmaceutically acceptable salts...
|
|
|
8324226 |
Therapeutic oxy-phenyl-aryl compounds and their use
The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain oxy phenyl aryl compounds (referred to herein as OPA compounds), as described...
|
|
|
8318761 |
Substituted arylsulfonamides as antiviral agents
The invention relates to substituted arylsulfonamides of formula (I) and methods for their preparation as well as their use for the production of medicaments for the treatment and/or prophylaxis of...
|
|
|
8318776 |
Pyridine compound, pesticidal composition and method of controlling pests
A pyridine compound represented by the following general formula (1); the pyridine compound in which R1 is a C1-C3 fluoroalkyl group or a C1-C3 fluoroalkoxy group; the pyridine compound in which R2...
|
|
|
8318792 |
Therapeutic agent for amyotrophic lateral sclerosis
A method for treating amyotrophic lateral sclerosis is disclosed wherein a compound having xanthine dehydrogenase inhibiting activity is administered.
|
|
|
8299076 |
Crystalline forms of 2-(2-flouro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide
Disclosed are crystalline forms of 2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimet
hyl-6-oxo-1,6-dihydropyridine-3-carboxamide useful in the treatment of hyperproliferative diseases,...
|
|
|
8299074 |
P38 MAP kinase inhibitors
The present disclosure relates to compounds of formula (I): which are inhibitors of p38 mitogen-activated protein kinase enzymes, particularly the alpha and gamma kinase sub-types thereof, and...
|
|
|
8299082 |
1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives
1,2,4-Triazolylaminoaryl(heteroaryl)sulfonamide derivatives of formula (I), pharmaceutically acceptable salts thereof, processes for the manufacture of...
|
|
|
8299073 |
P38 MAP kinase inhibitors
The invention relates to compounds of formula (I): or a pharmaceutically acceptable salt thereof, including all stereoisomers, tautomers and isotopic derivatives thereof, which are inhibitors of...
|
|
|
8293770 |
Pyrrolidine derivatives as NK-3 receptor antagonists
The present invention relates to a compound of formula I wherein Ar1, Ar2, R1, R2, R3, n, o, and p are as described hereinor to a pharmaceutically active salt, to all stereoisomeric forms,...
|
|
|
8293771 |
p38 MAP kinase inhibitors
There is provided a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, including all tautomers thereof, compositions comprising the same, use of said compound and...
|
|
|
8293748 |
p38 MAP kinase inhibitors
There are provided inter alia compounds of formula (I) wherein R1, Ar, L, X, R3 and Q are as defined in the specification for use in therapy, especially in the treatment of inflammatory diseases.
|
|
|
8288371 |
Ortho pyrrolidine, benzyl-substituted heterocycle CCR1 antagonists for autoimmune diseases and inflammation
Compounds of the formula are disclosed. The compounds are CCR1 antagonists which are useful for the treatment and prevention of inflammatory and autoimmune diseases. Other embodiments are also...
|
|
|
8288403 |
Heterocyclic gamma secretase modulators
The invention relates to methods for the treatment of Alzheimer's disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct...
|
|
|
8278317 |
Potassium channel inhibitors
The present invention relates to compounds having the structure (I) useful as potassium channel inhibitors to treat cardiac arrhythmias, and the like.
|
|
|
8278334 |
Cyclic amine BACE-1 inhibitors having a benzamide substituent
Disclosed are compounds of the formula or a pharmaceutically acceptable salt or solvate thereof, wherein R1 is R is —C(O)—N(R27)(R28) or and the remaining variables are as defined in the spe...
|
|
|
8247431 |
Heterocyclic hydrazide compound and pesticidal use of the same
A hydrazide compound represented by the formula (I), an N-oxide thereof or suitable salt thereof: has excellent pesticidal activity.
|
|
|
8242103 |
Sulphamides for treatment of cancer
Bridged bicyclic sulphamides of formula (I) are disclosed for treatment of cancer.
|
|
|
8242118 |
Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
The present invention relates to a sulfonamide derivative which is useful as an active ingredient of pharmaceutical preparations. The sulfonamide derivatives of the present invention have CCR3 (CC...
|
|
|
8231888 |
Isoxazolines for controlling invertebrate pests
Disclosed are compounds of Formula 1, including all geometric and stereoisomers, N-oxides, and salts thereof, wherein A1, A2, A3, A4, A5 and A6 are independently selected from the group consisting...
|
|
|
8232302 |
Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
The present invention relates to modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Regulator (“CFTR”), compositions thereof...
|
|
|
8227461 |
Isoxazoles
The present invention is concerned with novel isoxazole derivatives of formula I wherein X, R1, R2, R3, R4 and R5 are as described herein, as well as pharmaceutically acceptable salts and esters...
|
|
|
8222246 |
Substituted isoxazoles
The present invention is concerned with novel hydroxy-methyl isoxazole derivatives of formula I wherein R1, R2 and R3 are as described herein, as well as pharmaceutically acceptable salts and...
|